Forward Health

forwardhealth.co

Forward is a mobile communication platform empowering health and care teams to spend more time with their patients, doing the things that matter. We are a team of doctors and technology experts united by a profound mission: to connect healthcare. Find Forward on your app store today.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Medical

STRAMSEN BIOTECH, INC. TO FUND NEXT PHASES OF CLINICAL TRIALS AND ADDITIONAL MEDICINE DISCOVERY RESEARCH

Stramsen Biotech, Inc | December 17, 2020

news image

Stramsen Biotech, Inc, a professional group of medication researchers from the Houston, Texas territory comprises of scientists who devote their lives each day to investigating and exploring both the cycles and logical instruments hidden the world we live in today. Colleagues have gotten a few honors and awards for research ventures, with a significant number of their activities and distributions accessible upon demand. Individuals incorporate PhD and University level professors who specialize i...

Read More

Industrial Impact

OMASS THERAPEUTICS TO PRESENT AT UPCOMING CONFERENCESOMASS THERAPEUTICS TO PRESENT AT UPCOMING CONFERENCES

OMass Therapeutics | February 21, 2022

news image

OMass Therapeutics a biotechnology company identifying medicines against highly validated target ecosystems, is pleased to confirm that it will be presenting at a number of upcoming banking, business and scientific conferences, as detailed below. “As we develop our unique drug discovery platform, OdyssION™, and progress our pipeline of small molecule therapeutics in rare diseases and immunological conditions, targeting solute carriers, complex-bou...

Read More

Industrial Impact

THINKCYTE'S SHARES APPLICATIONS OF GHOST CYTOMETRY WITH INDUSTRIAL AND ACADEMIC THOUGHT LEADERS

ThinkCyte Inc. | July 12, 2022

news image

ThinkCyte Inc., a biotechnology company pioneering novel cell analysis and sorting instruments, announced that applications of its Ghost Cytometry technology were presented at several leading industry meetings. In May, the company was selected to present applications of the platform to experts in drug discovery at the prestigious Keystone Symposia. The company was also selected to deliver a podium presentation at the 2022 International Association for the Advancement of Cytometry's annual me...

Read More

Medical, Diagnostics

ASTELLAS AND POSEIDA THERAPEUTICS ANNOUNCE STRATEGIC INVESTMENT TO SUPPORT POSEIDA'S COMMITMENT TO REDEFINING CANCER CELL THERAPY

PRNewswire | August 08, 2023

news image

Astellas Pharma Inc. and Poseida Therapeutics, Inc. announced a strategic investment to support the advancement of Poseida's commitment to redefining cancer cell therapy. Under the terms of the transaction agreements, Astellas will invest a total of $50 million, including $25 million to acquire 8,333,333 shares of common stock of Poseida (approximately 8.8% of the outstanding common stock of Poseida) at $3.00 per share in a private placement and a one-time $25 million paymen...

Read More
news image

Medical

STRAMSEN BIOTECH, INC. TO FUND NEXT PHASES OF CLINICAL TRIALS AND ADDITIONAL MEDICINE DISCOVERY RESEARCH

Stramsen Biotech, Inc | December 17, 2020

Stramsen Biotech, Inc, a professional group of medication researchers from the Houston, Texas territory comprises of scientists who devote their lives each day to investigating and exploring both the cycles and logical instruments hidden the world we live in today. Colleagues have gotten a few honors and awards for research ventures, with a significant number of their activities and distributions accessible upon demand. Individuals incorporate PhD and University level professors who specialize i...

Read More
news image

Industrial Impact

OMASS THERAPEUTICS TO PRESENT AT UPCOMING CONFERENCESOMASS THERAPEUTICS TO PRESENT AT UPCOMING CONFERENCES

OMass Therapeutics | February 21, 2022

OMass Therapeutics a biotechnology company identifying medicines against highly validated target ecosystems, is pleased to confirm that it will be presenting at a number of upcoming banking, business and scientific conferences, as detailed below. “As we develop our unique drug discovery platform, OdyssION™, and progress our pipeline of small molecule therapeutics in rare diseases and immunological conditions, targeting solute carriers, complex-bou...

Read More
news image

Industrial Impact

THINKCYTE'S SHARES APPLICATIONS OF GHOST CYTOMETRY WITH INDUSTRIAL AND ACADEMIC THOUGHT LEADERS

ThinkCyte Inc. | July 12, 2022

ThinkCyte Inc., a biotechnology company pioneering novel cell analysis and sorting instruments, announced that applications of its Ghost Cytometry technology were presented at several leading industry meetings. In May, the company was selected to present applications of the platform to experts in drug discovery at the prestigious Keystone Symposia. The company was also selected to deliver a podium presentation at the 2022 International Association for the Advancement of Cytometry's annual me...

Read More
news image

Medical, Diagnostics

ASTELLAS AND POSEIDA THERAPEUTICS ANNOUNCE STRATEGIC INVESTMENT TO SUPPORT POSEIDA'S COMMITMENT TO REDEFINING CANCER CELL THERAPY

PRNewswire | August 08, 2023

Astellas Pharma Inc. and Poseida Therapeutics, Inc. announced a strategic investment to support the advancement of Poseida's commitment to redefining cancer cell therapy. Under the terms of the transaction agreements, Astellas will invest a total of $50 million, including $25 million to acquire 8,333,333 shares of common stock of Poseida (approximately 8.8% of the outstanding common stock of Poseida) at $3.00 per share in a private placement and a one-time $25 million paymen...

Read More